Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Biodurable Ophthalmic Drug Delivery System
1.2 Key Market Segments
1.2.1 Biodurable Ophthalmic Drug Delivery System Segment by Type
1.2.2 Biodurable Ophthalmic Drug Delivery System Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Biodurable Ophthalmic Drug Delivery System Market Overview
2.1 Global Market Overview
2.1.1 Global Biodurable Ophthalmic Drug Delivery System Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biodurable Ophthalmic Drug Delivery System Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Biodurable Ophthalmic Drug Delivery System Market Competitive Landscape
3.1 Global Biodurable Ophthalmic Drug Delivery System Sales by Manufacturers (2019-2024)
3.2 Global Biodurable Ophthalmic Drug Delivery System Revenue Market Share by Manufacturers (2019-2024)
3.3 Biodurable Ophthalmic Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biodurable Ophthalmic Drug Delivery System Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biodurable Ophthalmic Drug Delivery System Sales Sites, Area Served, Product Type
3.6 Biodurable Ophthalmic Drug Delivery System Market Competitive Situation and Trends
3.6.1 Biodurable Ophthalmic Drug Delivery System Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biodurable Ophthalmic Drug Delivery System Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Biodurable Ophthalmic Drug Delivery System Industry Chain Analysis
4.1 Biodurable Ophthalmic Drug Delivery System Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Biodurable Ophthalmic Drug Delivery System Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Biodurable Ophthalmic Drug Delivery System Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biodurable Ophthalmic Drug Delivery System Sales Market Share by Type (2019-2024)
6.3 Global Biodurable Ophthalmic Drug Delivery System Market Size Market Share by Type (2019-2024)
6.4 Global Biodurable Ophthalmic Drug Delivery System Price by Type (2019-2024)
7 Biodurable Ophthalmic Drug Delivery System Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biodurable Ophthalmic Drug Delivery System Market Sales by Application (2019-2024)
7.3 Global Biodurable Ophthalmic Drug Delivery System Market Size (M USD) by Application (2019-2024)
7.4 Global Biodurable Ophthalmic Drug Delivery System Sales Growth Rate by Application (2019-2024)
8 Biodurable Ophthalmic Drug Delivery System Market Segmentation by Region
8.1 Global Biodurable Ophthalmic Drug Delivery System Sales by Region
8.1.1 Global Biodurable Ophthalmic Drug Delivery System Sales by Region
8.1.2 Global Biodurable Ophthalmic Drug Delivery System Sales Market Share by Region
8.2 North America
8.2.1 North America Biodurable Ophthalmic Drug Delivery System Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biodurable Ophthalmic Drug Delivery System Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biodurable Ophthalmic Drug Delivery System Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biodurable Ophthalmic Drug Delivery System Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biodurable Ophthalmic Drug Delivery System Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Glaukos Corp
9.1.1 Glaukos Corp Biodurable Ophthalmic Drug Delivery System Basic Information
9.1.2 Glaukos Corp Biodurable Ophthalmic Drug Delivery System Product Overview
9.1.3 Glaukos Corp Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.1.4 Glaukos Corp Business Overview
9.1.5 Glaukos Corp Biodurable Ophthalmic Drug Delivery System SWOT Analysis
9.1.6 Glaukos Corp Recent Developments
9.2 Ocular Therapeutix
9.2.1 Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System Basic Information
9.2.2 Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System Product Overview
9.2.3 Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.2.4 Ocular Therapeutix Business Overview
9.2.5 Ocular Therapeutix Biodurable Ophthalmic Drug Delivery System SWOT Analysis
9.2.6 Ocular Therapeutix Recent Developments
9.3 Santen Pharmaceutical
9.3.1 Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System Basic Information
9.3.2 Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System Product Overview
9.3.3 Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.3.4 Santen Pharmaceutical Biodurable Ophthalmic Drug Delivery System SWOT Analysis
9.3.5 Santen Pharmaceutical Business Overview
9.3.6 Santen Pharmaceutical Recent Developments
9.4 pSivida
9.4.1 pSivida Biodurable Ophthalmic Drug Delivery System Basic Information
9.4.2 pSivida Biodurable Ophthalmic Drug Delivery System Product Overview
9.4.3 pSivida Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.4.4 pSivida Business Overview
9.4.5 pSivida Recent Developments
9.5 Clearside Biomedical
9.5.1 Clearside Biomedical Biodurable Ophthalmic Drug Delivery System Basic Information
9.5.2 Clearside Biomedical Biodurable Ophthalmic Drug Delivery System Product Overview
9.5.3 Clearside Biomedical Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.5.4 Clearside Biomedical Business Overview
9.5.5 Clearside Biomedical Recent Developments
9.6 Bausch Health
9.6.1 Bausch Health Biodurable Ophthalmic Drug Delivery System Basic Information
9.6.2 Bausch Health Biodurable Ophthalmic Drug Delivery System Product Overview
9.6.3 Bausch Health Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.6.4 Bausch Health Business Overview
9.6.5 Bausch Health Recent Developments
9.7 AptarGroup
9.7.1 AptarGroup Biodurable Ophthalmic Drug Delivery System Basic Information
9.7.2 AptarGroup Biodurable Ophthalmic Drug Delivery System Product Overview
9.7.3 AptarGroup Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.7.4 AptarGroup Business Overview
9.7.5 AptarGroup Recent Developments
9.8 Boehringer Ingelheim
9.8.1 Boehringer Ingelheim Biodurable Ophthalmic Drug Delivery System Basic Information
9.8.2 Boehringer Ingelheim Biodurable Ophthalmic Drug Delivery System Product Overview
9.8.3 Boehringer Ingelheim Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.8.4 Boehringer Ingelheim Business Overview
9.8.5 Boehringer Ingelheim Recent Developments
9.9 Allergan
9.9.1 Allergan Biodurable Ophthalmic Drug Delivery System Basic Information
9.9.2 Allergan Biodurable Ophthalmic Drug Delivery System Product Overview
9.9.3 Allergan Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.9.4 Allergan Business Overview
9.9.5 Allergan Recent Developments
9.10 Re-Vana Therapeutics
9.10.1 Re-Vana Therapeutics Biodurable Ophthalmic Drug Delivery System Basic Information
9.10.2 Re-Vana Therapeutics Biodurable Ophthalmic Drug Delivery System Product Overview
9.10.3 Re-Vana Therapeutics Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.10.4 Re-Vana Therapeutics Business Overview
9.10.5 Re-Vana Therapeutics Recent Developments
9.11 PolyActiva
9.11.1 PolyActiva Biodurable Ophthalmic Drug Delivery System Basic Information
9.11.2 PolyActiva Biodurable Ophthalmic Drug Delivery System Product Overview
9.11.3 PolyActiva Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.11.4 PolyActiva Business Overview
9.11.5 PolyActiva Recent Developments
9.12 Genentech
9.12.1 Genentech Biodurable Ophthalmic Drug Delivery System Basic Information
9.12.2 Genentech Biodurable Ophthalmic Drug Delivery System Product Overview
9.12.3 Genentech Biodurable Ophthalmic Drug Delivery System Product Market Performance
9.12.4 Genentech Business Overview
9.12.5 Genentech Recent Developments
10 Biodurable Ophthalmic Drug Delivery System Market Forecast by Region
10.1 Global Biodurable Ophthalmic Drug Delivery System Market Size Forecast
10.2 Global Biodurable Ophthalmic Drug Delivery System Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biodurable Ophthalmic Drug Delivery System Market Size Forecast by Country
10.2.3 Asia Pacific Biodurable Ophthalmic Drug Delivery System Market Size Forecast by Region
10.2.4 South America Biodurable Ophthalmic Drug Delivery System Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biodurable Ophthalmic Drug Delivery System by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Biodurable Ophthalmic Drug Delivery System Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biodurable Ophthalmic Drug Delivery System by Type (2025-2030)
11.1.2 Global Biodurable Ophthalmic Drug Delivery System Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biodurable Ophthalmic Drug Delivery System by Type (2025-2030)
11.2 Global Biodurable Ophthalmic Drug Delivery System Market Forecast by Application (2025-2030)
11.2.1 Global Biodurable Ophthalmic Drug Delivery System Sales (K Units) Forecast by Application
11.2.2 Global Biodurable Ophthalmic Drug Delivery System Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
